NCT04253717

Brief Summary

This study protocol was designed to establish the feasibility of conducting a motor control exercise program with pregnant women presenting a history of lumbopelvic pain (LBPP) in order to reduce LBPP occurrence or limit its intensity. This randomized controlled trial also aims to preliminary assess the effectiveness of the program. To do so, 40 pregnant women with a history of LBPP will be recruited and randomly allocated to one of 2 groups: control (20 participants) or intervention (20 participants). The control group will receive standard care, including basic information on what to do when suffering from LBPP. The intervention group will participate in a weekly 40-minute group session and two more 40-minute weekly home exercise sessions. The motor control exercise program will be designed to target strengthening of the lumbo-pelvic-hip core muscles in order to improve stabilization and protection of the spine and pelvis. Participants of this group will also receive standard care. Adequate prevention and treatment of LBPP, experienced by women during pregnancy, should help reduce LBPP occurrence or limit its intensity during pregnancy.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
32

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 28, 2020

Completed
8 days until next milestone

First Posted

Study publicly available on registry

February 5, 2020

Completed
1.2 years until next milestone

Study Start

First participant enrolled

April 2, 2021

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 14, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 14, 2022

Completed
Last Updated

May 9, 2023

Status Verified

May 1, 2023

Enrollment Period

1.7 years

First QC Date

January 28, 2020

Last Update Submit

May 8, 2023

Conditions

Keywords

Physical activityNon-invasive treatment

Outcome Measures

Primary Outcomes (7)

  • Recruitment rate

    Defined as the ability to recruit 40 eligible women, willing to participate to the study

    Baseline (Pre-intervention)

  • Retention rate

    Defined as the completion of follow-up questionnaire by ≥ 80% of women

    Baseline (Post-intervention)

  • Adherence rate

    Defined as attendance to ≥75% of group sessions and ≥ 75% completion of home sessions

    Baseline (Post-intervention)

  • Safety of the intervention

    Determined based on the number of adverse events and defined as nature of adverse events

    16 weeks follow-up

  • Safety of the intervention

    Determined based on the number of adverse events and defined as nature of adverse events

    Week 16 (Post-intervention)

  • Acceptability of the intervention

    Determined based on how the intervention is perceived by pregnant women (assessed using a 5-point Likert scale : higher score mean a better outcome)

    16 weeks follow-up

  • Acceptability of the intervention

    Determined based on how the intervention is perceived by pregnant women (assessed using a 5-point Likert scale : higher score mean a better outcome)

    Week 16 (Post-intervention)

Secondary Outcomes (11)

  • Functional disability

    Baseline (Pre-intervention) and week 16 (Post-intervention)

  • Fear avoidance behaviors

    Baseline (Pre-intervention) and week 16 (Post-intervention)

  • Level of anxiety

    Baseline (Pre-intervention) and week 16 (Post-intervention)

  • Depression

    Baseline (Pre-intervention) and week 16 (Post-intervention)

  • Physical activity levels

    Baseline (Pre-intervention) and week 16 (Post-intervention)

  • +6 more secondary outcomes

Study Arms (2)

Motor control exercise program

EXPERIMENTAL

Participants will be physically trained during pregnancy and will receive the standard care including basic information on what to do when suffering from lumbopelvic pain.

Other: Motor control exercise program

Control

NO INTERVENTION

Participants will receive the standard care including basic information on what to do when suffering from lumbopelvic pain.

Interventions

Structure physical training aimed at strengthening muscles of the lumbo-pelvic-hip core complex in order to improve stabilization and alignment of the spine and pelvis.

Motor control exercise program

Eligibility Criteria

Age18 Years - 40 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Being pregnant of one fetus
  • Being ≤ 20 weeks pregnant
  • Presenting a history of lumbopelvic pain

You may not qualify if:

  • Inflammatory rheumatic disease
  • Infectious disease
  • Neuromuscular disease
  • Vascular disease
  • Connective tissue disease
  • Severe disabling pain
  • Neurologic signs and symptoms

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Université du Québec à Trois-Rivières

Trois-Rivières, Quebec, G8Z 4M3, Canada

Location

Related Publications (1)

  • Daneau C, Marchand AA, Bussieres A, O'Shaughnessy J, Ruchat SM, Descarreaux M. Effects of a motor control exercise program on lumbopelvic pain recurrences and intensity in pregnant women with a history of lumbopelvic pain: a study protocol for a randomized controlled feasibility trial. Pilot Feasibility Stud. 2022 Mar 21;8(1):65. doi: 10.1186/s40814-022-01024-0.

MeSH Terms

Conditions

Motor Activity

Condition Hierarchy (Ancestors)

Behavior

Study Officials

  • Martin Descarreaux, DC, PhD

    Université du Québec à Trois-Rivières

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

January 28, 2020

First Posted

February 5, 2020

Study Start

April 2, 2021

Primary Completion

December 14, 2022

Study Completion

December 14, 2022

Last Updated

May 9, 2023

Record last verified: 2023-05

Locations